CHRONIC GRAFT VERSUS HOST DISEASE
Clinical trials for CHRONIC GRAFT VERSUS HOST DISEASE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC GRAFT VERSUS HOST DISEASE trials appear
Sign up with your email to follow new studies for CHRONIC GRAFT VERSUS HOST DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug tested for chronic Graft-Versus-Host disease in india
Disease control Not yet recruitingThis study tests the safety of a drug called belumosudil in 26 Indian patients aged 12 and older who have chronic graft-versus-host disease (cGVHD), a complication after a stem cell transplant. Participants must have tried at least two prior treatments. The study lasts up to 12 m…
Matched conditions: CHRONIC GRAFT VERSUS HOST DISEASE
Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Blood test may predict transplant complication before symptoms appear
Knowledge-focused Not yet recruitingThis study aims to find proteins in the blood that can predict chronic graft-versus-host disease (cGVHD), a serious complication after stem cell transplants. Researchers will analyze blood samples from 1,500 transplant recipients to build a model that helps doctors diagnose cGVHD…
Matched conditions: CHRONIC GRAFT VERSUS HOST DISEASE
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC